News/Events - Newsletter

NEWS FROM OSTROLENK, FABER, GERB & SOFFEN, LLP
April 2004

Peter S. Sloane successfully represented Novartis International Pharmaceutical, Ltd. in an opposition against an application to register the trademark DERMAVIR for "vaccines and vaccine adjuvants" filed by Genetic Immunity, LLC. Novartis is the owner of the mark DENAVIR as used and registered for "antivirals" and "preparations for the treatment of cold sores and related skin disorders." In upholding the opposition, the Trademark Trial and Appeal Board found that Novartis had demonstrated priority and a likelihood of confusion between the marks. If you would like to receive a copy of the decision, please contact Peter Sloane at psloane@ostrolenk.com.

Charles P. LaPolla and Mary Fontenot secured the entry of a Consent Judgement on behalf of Six Flags in a suit for trademark infringement against a hotel in Oklahoma City using the name FRONTIER CITY INN. The Defendant must change the name of its hotel to another name not incorporating the term FRONTIER because of Six Flag's ownership of the trademark FRONTIER CITY for an amusement park located in Oklahoma City.

On April 1, 2004 Marc Lieberstein will be speaking at the New York State Bar Association Intellectual Property Law Section program entitled "The Copyright Office Comes to New York." The program will take place at the Benjamin N. Cardozo School of Law, 55 Fifth Avenue, New York, New York beginning at 8:30 a.m. Breakfast, Lunch and Cocktails will be served. If you would like to attend please call or email Mr. Lieberstein at mlieberstein@ostrolenkcom or visit www.nysba.org/ipl.